First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented…
Unveiling the dual role of HIV integrase in viral replication
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most…
Toxic compounds from heated e-cigarette fluids can damage lung cells
A study by University of California, Riverside, scientists has found that two toxic chemicals can form when the main ingredient…
How COVID mRNA vaccines may make cancer treatments more effective
A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…
Antibody discovery could provide new treatment options for aggressive breast cancers
A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.…
Common test to assess viability of IVF embryos may be flawed
A test deployed in many fertility clinics to assess the viability of embryos for use in IVF is…
A new way to monitor chemotherapy drug behavior inside cells
Scientists have made incredible progress in developing cancer therapies that help patients across cancer types. However, they face…
Nuclear binding protein identified as key contributor to trisomy 21-related CHDs
Three copies of chromosome 21 causes Down syndrome (DS), and roughly half of children born each year in…
HMGN1 gene linked to heart problems in people with Down syndrome
Nearly half of all babies born with Down syndrome face congenital heart defects, often involving serious malformations that…
New drug combination shows promise in treating colorectal cancer
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it…
New insights into how the blood-brain barrier safeguards the brain
By decoding the blood-brain barrier’s intricate structure and function, researchers are paving the way for new therapies that…
Researchers develop a novel approach to monitor CD8⁺ T cell activity over time
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key…